These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 17120369)
61. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Sacchettini JC; Rubin EJ; Freundlich JS Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742 [TBL] [Abstract][Full Text] [Related]
62. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates. Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484 [TBL] [Abstract][Full Text] [Related]
63. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease]. Vishnevskiĭ BI; Steklova LN Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317 [TBL] [Abstract][Full Text] [Related]
64. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823 [TBL] [Abstract][Full Text] [Related]
65. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis. Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749 [TBL] [Abstract][Full Text] [Related]
66. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154 [TBL] [Abstract][Full Text] [Related]
67. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897 [TBL] [Abstract][Full Text] [Related]
68. Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005. Mokaddas E; Ahmad S; Samir I Int J Tuberc Lung Dis; 2008 Mar; 12(3):319-25. PubMed ID: 18284839 [TBL] [Abstract][Full Text] [Related]
69. Demanding an end to tuberculosis: treatment of tuberculosis infection among persons living with and without HIV. Fargher J; Reuter A; Furin J Curr Opin HIV AIDS; 2019 Jan; 14(1):21-27. PubMed ID: 30407203 [TBL] [Abstract][Full Text] [Related]
71. [A new chapter in the history of tuberculosis]. Vandenbroucke-Grauls CM; Verhoef J Ned Tijdschr Geneeskd; 1993 Mar; 137(13):642-5. PubMed ID: 8469295 [No Abstract] [Full Text] [Related]
72. TB revisited! Moore E Pa Nurse; 1992 Oct; 47(10):5. PubMed ID: 1408280 [No Abstract] [Full Text] [Related]
73. Drug resistant Mycobacterium tuberculosis in Saudi Arabia. Arya SC Saudi Med J; 2002 Apr; 23(4):475. PubMed ID: 11953781 [No Abstract] [Full Text] [Related]
74. Resource constraints and care of HIV complications among TB in-patients in Malawi. Muula AS; Phiri A Int J Tuberc Lung Dis; 2002 Jul; 6(7):645-6. PubMed ID: 12102306 [No Abstract] [Full Text] [Related]